On December 12, 2022, Gain Therapeutics, Inc. appointed Gianluca Fuggetta, its Finance Director, Corporate Reporting, as the Company's Principal Accounting Officer. Mr. Fuggetta, age 34, has served as the Company's Finance Director, Corporate Reporting since July 2022. Prior to joining the Company, Mr. Fuggetta held various positions of increasing responsibility at PricewaterhouseCoopers from September 2013 until June 2022, most recently holding the position of Assurance Manager.

He earned a B.S. in Business Administration and Management at the Università Cattolica del Sacro Cuore and a Master's in Accounting, Auditing and Control at the Università Bocconi. The Company's Chief Financial Officer, Salvatore Calabrese, who was previously serving as both Principal Financial Officer and Principal Accounting Officer, will continue serving as the Company's Principal Financial Officer.